Improving alcohol treatment for people living with HIV
Alcohol Research Consortium in HIV: Implementation Research Arm
['FUNDING_P01'] · JOHNS HOPKINS UNIVERSITY · NIH-10922755
This study is looking at how to better help people with HIV cut down on alcohol use by providing support to clinics, so they can help patients stick to their treatment and feel healthier.
Quick facts
| Phase | ['FUNDING_P01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | JOHNS HOPKINS UNIVERSITY (nih funded) |
| Locations | 1 site (BALTIMORE, UNITED STATES) |
| Trial ID | NIH-10922755 on ClinicalTrials.gov |
What this research studies
This research focuses on enhancing the integration of alcohol reduction interventions into HIV care to improve medication adherence and health outcomes. It employs a multifaceted implementation strategy called practice facilitation, where a coach provides support and resources to HIV clinics. The study will evaluate how well these interventions are adopted and maintained in clinical settings, as well as their effectiveness in reducing unhealthy alcohol use among patients. The research will take place in several HIV clinics across Boston, San Diego, and Chapel Hill.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals living with HIV who also struggle with unhealthy alcohol use.
Not a fit: Patients who do not have HIV or do not engage in unhealthy alcohol use may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to better health outcomes for individuals living with HIV by improving their adherence to treatment and reducing alcohol-related barriers.
How similar studies have performed: Previous research has shown that implementing evidence-based interventions can significantly improve health outcomes in similar populations, suggesting a promising potential for this approach.
Where this research is happening
BALTIMORE, UNITED STATES
- JOHNS HOPKINS UNIVERSITY — BALTIMORE, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: CHANDER, GEETANJALI — JOHNS HOPKINS UNIVERSITY
- Study coordinator: CHANDER, GEETANJALI
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Acquired Immune Deficiency Syndrome, Acquired Immune Deficiency Syndrome Virus, Acquired Immunodeficiency Syndrome, Acquired Immunodeficiency Syndrome Virus